Porcine rotavirus: why it persists and where true protection lies

Rotaviruses are double-stranded RNA viruses widely distributed in animal production. Historically grouped within the Reoviridae family, today they are part of a viral classification reorganized into two families: Sedoreoviridae and Spinareoviridae. In pigs, they infect the differentiated enterocytes of the small intestine and cause acute diarrhea, dehydration, decreased feed intake and growth retardation, with a particularly marked impact on suckling and nursery piglets.

Rotavirus continues to be one of the main causes of diarrhea in piglets, even in well-managed farms. A training module with Prof. Dr. Thomas Vahlenkamp (University of Leipzig) reviews why eradication is not realistic, but effective control is. These are the key points that help frame the problem in its proper dimension and guide the conversation with the client.

1. It persists because its biology and management give it the advantage

Rotavirus combines high genetic diversity —with several viral groups and multiple genotypes within each— and remarkable environmental stability. Cross-protection between groups is very limited and, in the field, it is common to detect coinfections by two or even three groups circulating simultaneously on the same farm.

Added to this biology is a production factor: large batches of same-age animals amplify clinical waves. Subclinically infected animals, which show no signs but continue to shed virus, sustain its circulation between outbreaks. And when a new genotype is introduced —through replacement or animal movement—, herd immunity does not respond and a clinical picture appears seemingly "out of nowhere".

2. Why piglets are so vulnerable

Two factors explain the high susceptibility during the first three to four weeks of life:

• Intestinal immaturity: Rotavirus damages the villous epithelium of the small intestine, especially from the mid-jejunum to the ileum. In young piglets, this results in villous atrophy, malabsorption and diarrhea, with slower functional recovery than in older animals.
• Limited passive immunity: the porcine placenta is epitheliochorial, so no antibodies are transferred to the fetus during gestation. The piglet is born immunologically naïve and rely entirely on colostrum and milk.

This combination leaves a critical window that prevention needs to cover with immunity transferred from the sow.

3. Detecting rotavirus is not the same as explaining the clinical picture

In the field, rotavirus rarely acts alone. Other enteric viruses coexist —astrovirus, calicivirus, kobuvirus, sapovirus, coronavirus— that can modulate the clinical picture. The intestinal microbiota and the quality of management also play a role.

For this reason, the laboratory results must be interpreted together with the farm's clinical history: age of affected animals, management, movements and response to previous interventions.

• Request multiplex PCR to type the viral group and, when relevant, the genotype.
• Consider coinfections when the response to vaccination or management is not as expected.
• A higher viral load or the combination of several groups reinforces the hypothesis of rotavirus as the primary agent.

The definitive diagnosis is made on the farm, not in the laboratory.

4. Protection lives in the mucosa

Since rotavirus replicates exclusively in the differentiated enterocytes of the jejunum, protection depends on local mucosal immunity, mediated by secretory IgA, not on systemic IgG.

Colostrum first provides IgG, which passes into the systemic circulation; later, milk provides secretory IgA, essential to neutralize the virus in the intestinal lumen. That is why the central prevention strategy is to vaccinate the sow so that, via colostrum and milk, she transfers that immunity to the piglet.

This also has an important diagnostic implication: serum IgG titers are only an indirect correlate of real protection. Good systemic seroconversion does not, by itself, guarantee intestinal-level protection.

5. Four conditions for realistic control

Eradicating rotavirus in commercial farms is not feasible. What is feasible is to reduce infection pressure and protect the critical window of the first weeks of life, by combining four pillars:

• Sow vaccination aligned with the diagnosis of the circulating group.
• Colostrum and milk management: sow in good condition, sufficient production and adequate intake by the piglet.
• Biosecurity: cleaning, disinfection and continuous removal of feces to reduce exposure load.
• Team communication: the vaccine induces a response in the sow, it does not directly protect the piglet. Without proper management of passive transfer, immunization loses value.

In the full module, Prof. Vahlenkamp explores in greater depth the epidemiological dynamics of the virus, the criteria for choosing between commercial and autogenous vaccines given the variability of circulating genotypes, and strategies for evaluating mucosal immunity beyond serum antibody titers.